NRNP 6552 Final Exam – 2026/2027- Edition 100 Questions And
100% Verified Answers
Overview:
contraception, STI management, GYN disorders, obstetric care, postpartum complications,
menopause, infertility, and screening guidelines. Integrates USPSTF, CDC, and ACOG
protocols. Emphasizes clinical decision-making, pharmacology, and evidence-based
management across the reproductive lifespan from menarche through postmenopause.
Answers bolded Green + Rationales
1. CDC MEC Cat 3 for CHC includes:
A. Lactation <21d pp
B. Migraine with aura
C. Controlled HTN
D. BMI 35
Rationale: Migraine with aura = Cat 3 CHC, Cat 4 if + smoking age ≥35.
2. LNG-IUD initial SE most common?
A. Weight gain
B. Irregular spotting 3-6mo
C. Acne
D. Depression
Rationale: Irregular bleeding common first 3-6mo, then amenorrhea 20% at 1yr.
3. DMPA return to fertility after stopping?
A. 1 month
B. 3 months
C. 9-10 months average
D. 2 years
Rationale: Median 10mo, up to 18mo. Counsel on delay.
4. Nexplanon insertion timing for immediate efficacy?
A. Any time
B. Days 1-5 menses or with backup 7d
C. Only follicular
D. Postpartum only
Rationale: Days 1-5 immediate. Otherwise backup 7d.
5. CHC contraindication BMI?
A. >25
B. >30
C. No absolute CI, but >30 + other VTE risk = caution
D. >40
Rationale: BMI alone not CI, but VTE risk rises. Consider progestin-only.
6. UPA EC efficacy reduced by?
A. Food
B. BMI >30, taking after ovulation
C. Age >40
, D. PCOS
Rationale: Reduced if BMI >30 and if LH surge already occurred.
7. USPSTF HPV primary screen age?
A. 21
B. 25
C. 30-65 q5yr
D. 40
Rationale: Age 30-65: HPV alone q5yr OR co-test q5yr OR Pap q3yr.
8. CIN 3 management?
A. Observe
B. Excision: LEEP/CKC
C. Hysterectomy all
D. Chemo
Rationale: CIN 3 = HSIL. Excision preferred. Hysterectomy if no fertility desire.
9. GC test of cure needed when?
A. All cases
B. Pharyngeal GC only
C. Urogenital GC
D. Never
Rationale: TOC 7-14d for pharyngeal only. Others not routine if s/s resolve.
10. Syphilis Jarisch-Herxheimer reaction =?
A. Allergic rxn
B. Fever, HA, myalgia 24h post-PCN
C. Treatment failure
D. Reinfection
Rationale: Cytokine release from treponeme death. Tx with antipyretics.
11. Latent syphilis unknown duration tx?
A. PCN G 2.4M U x1
B. PCN G 2.4M U IM weekly x3
C. Doxy 14d
D. Azithro x1
Rationale: Late latent/unknown = 7.2M U total over 3 weeks.
12. BV in pregnancy tx?
A. No tx asymptomatic
B. Metronidazole 500mg BID 7d or 250mg TID 7d
C. Clinda cream
D. 2g x1
Rationale: Oral tx all symptomatic. Screen/tx if prior PTB.
13. Candida glabrata VVC tx?
A. Fluconazole 150mg
B. Boric acid 600mg vag x14d
C. Nystatin
D. Terconazole 3d
Rationale: C. glabrata resistant to azoles. Boric acid or flucytosine.
14. PID inpatient criteria?
A. All cases
100% Verified Answers
Overview:
contraception, STI management, GYN disorders, obstetric care, postpartum complications,
menopause, infertility, and screening guidelines. Integrates USPSTF, CDC, and ACOG
protocols. Emphasizes clinical decision-making, pharmacology, and evidence-based
management across the reproductive lifespan from menarche through postmenopause.
Answers bolded Green + Rationales
1. CDC MEC Cat 3 for CHC includes:
A. Lactation <21d pp
B. Migraine with aura
C. Controlled HTN
D. BMI 35
Rationale: Migraine with aura = Cat 3 CHC, Cat 4 if + smoking age ≥35.
2. LNG-IUD initial SE most common?
A. Weight gain
B. Irregular spotting 3-6mo
C. Acne
D. Depression
Rationale: Irregular bleeding common first 3-6mo, then amenorrhea 20% at 1yr.
3. DMPA return to fertility after stopping?
A. 1 month
B. 3 months
C. 9-10 months average
D. 2 years
Rationale: Median 10mo, up to 18mo. Counsel on delay.
4. Nexplanon insertion timing for immediate efficacy?
A. Any time
B. Days 1-5 menses or with backup 7d
C. Only follicular
D. Postpartum only
Rationale: Days 1-5 immediate. Otherwise backup 7d.
5. CHC contraindication BMI?
A. >25
B. >30
C. No absolute CI, but >30 + other VTE risk = caution
D. >40
Rationale: BMI alone not CI, but VTE risk rises. Consider progestin-only.
6. UPA EC efficacy reduced by?
A. Food
B. BMI >30, taking after ovulation
C. Age >40
, D. PCOS
Rationale: Reduced if BMI >30 and if LH surge already occurred.
7. USPSTF HPV primary screen age?
A. 21
B. 25
C. 30-65 q5yr
D. 40
Rationale: Age 30-65: HPV alone q5yr OR co-test q5yr OR Pap q3yr.
8. CIN 3 management?
A. Observe
B. Excision: LEEP/CKC
C. Hysterectomy all
D. Chemo
Rationale: CIN 3 = HSIL. Excision preferred. Hysterectomy if no fertility desire.
9. GC test of cure needed when?
A. All cases
B. Pharyngeal GC only
C. Urogenital GC
D. Never
Rationale: TOC 7-14d for pharyngeal only. Others not routine if s/s resolve.
10. Syphilis Jarisch-Herxheimer reaction =?
A. Allergic rxn
B. Fever, HA, myalgia 24h post-PCN
C. Treatment failure
D. Reinfection
Rationale: Cytokine release from treponeme death. Tx with antipyretics.
11. Latent syphilis unknown duration tx?
A. PCN G 2.4M U x1
B. PCN G 2.4M U IM weekly x3
C. Doxy 14d
D. Azithro x1
Rationale: Late latent/unknown = 7.2M U total over 3 weeks.
12. BV in pregnancy tx?
A. No tx asymptomatic
B. Metronidazole 500mg BID 7d or 250mg TID 7d
C. Clinda cream
D. 2g x1
Rationale: Oral tx all symptomatic. Screen/tx if prior PTB.
13. Candida glabrata VVC tx?
A. Fluconazole 150mg
B. Boric acid 600mg vag x14d
C. Nystatin
D. Terconazole 3d
Rationale: C. glabrata resistant to azoles. Boric acid or flucytosine.
14. PID inpatient criteria?
A. All cases
